PIA
JAZZ icon

Piedmont Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Piedmont Investment Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,393
Closed -$438K – 352
2020
Q1 		$438K Buy
4,393
+681
+18% +$88K 0.02% 465
2019
Q4 		$554K Buy
3,712
+34
+0.9% +$4.63K 0.02% 481
2019
Q3 		$471K Sell
3,678
-3
-0.1% -$402 0.02% 540
2019
Q2 		$525K Sell
3,681
-256
-7% -$34.4K 0.02% 530
2019
Q1 		$563K Buy
3,937
+10
+0.3% +$1.3K 0.02% 478
2018
Q4 		$487K Buy
3,927
+15
+0.4% +$2.23K 0.02% 470
2018
Q3 		$658K Buy
3,912
+3,910
+195,500% +$672K 0.03% 410
2018
Q2 		$0 Buy
+2
New +$327 ﹤0.01% 2889

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Piedmont Investment Advisors's JAZZ Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 4,393 shares — an estimated $438K sold.

Piedmont Investment Advisors first reported a position in JAZZ in Q2 2018 and held it in 8 quarters. The position peaked at $658K in Q3 2018. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 4,393 Jazz Pharmaceuticals shares in Q2 2020, an estimated $438K.
  • Piedmont Investment Advisors first reported a position in Jazz Pharmaceuticals in Q2 2018 and held it in 8 quarters.
  • Piedmont Investment Advisors's Jazz Pharmaceuticals position peaked at $658K in Q3 2018.
  • 384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.